Trial intelligence / Profile preview

Bioequivalence of Azelaic Acid Foam in Rosacea

NCT02800148Phase 3Completed

Sponsor
Padagis
Start
Nov 2016
Primary completion
Oct 2017
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of Azelaic acid in rosacea, sponsored by Padagis. Started Nov 2016; status: completed.

02

Drugs

Azelaic acid
03

Conditions

rosacea

Beyond the preview

Go deeper on NCT02800148.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02800148.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call